The intestinal epithelium of adult mice is a highly self-renewing tissue that functions as a protective barrier for interfacing with the external environment, a source of secreted products, and a surface for absorption. Establishment and maintenance of the intestinal epithelium requires two temporally distinct types of stem/progenitor cells that are found during fetal development versus postnatally, distinguished by their gene expression and differential mechanisms of regulation. During embryonic development, the mouse intestine begins as a tube lined by pseudostratified epithelium harboring stem/progenitor cells dedicated to cellular expansion in a Wnt-pathway-independent manner. In preparation for postnatal life, the intestinal epithelium develops into a monolayer with villi (harboring differentiated cells) connected by intervillus regions with stem/ progenitor cells during the late prenatal period ($E14.5) (Chin et al., 2017 Punch biopsy isolation and RNA-seq of the granuloma-associated crypts (GACs) revealed 277 differentially expressed genes enriched in interferon-signaling targets, including Ly6a, which encodes the protein Sca-1 (Nusse et al., 2018 (Fordham et al., 2013; Mustata et al., 2013) in addition to Wnt/ R-spondin-independent proliferation, in contrast to that of Lgr5 + ISCs. Furthermore, the cells lacked differentiation markers and exhibited high expression of multiple fetal intestinal markers including Gja1, identified in previous gene expression profiling of fetal intestine (Mustata et al., 2013) . RNA-seq showed enrichment of fetal intestinal markers (and de-enrichment of stem cell, enterocyte, and Paneth cell markers) in the GACs, indicating that the crypts had adopted a fetal-like state in response to tissue damage. The investigators also examined whether loss of stem cell markers with adoption of a fetal-like gene expression pattern was a general crypt response to injury (Nusse et al., 2018 , 2016) , a population of label-retaining multipotent Paneth/enteroendocrine precursor cells (Buczacki et al., 2013) , and more developmentally mature enteroendocrine cells (Yan et al., 2017) . Taken together, these studies suggest that the cell type and regulatory mechanisms used during injury-induced regeneration differ from those used for steadystate epithelial renewal. In this case, Nusse and Savage et al. provide evidence that the source of Sca-1 + cells upon H. polygyrus infection is an epithelial cell derived from the Lgr5 + ISC, but the precise cell type giving rise to Sca-1 + cells and its position in the lineage hierarchy remain to be determined. Furthermore, Sca-1 is broadly expressed throughout the crypts, which exhibit significant heterogeneity by single-cell RNA-seq analysis, so it is likely that additional markers will be needed to prospectively identify a fetal-like stem/progenitor sub-population mediating this regeneration.
Expression of fetal markers in response to tissue injury has been recently reported in multiple contexts including NSAID drug-mediated injury to gastric epithelium (Fernandez Vallone et al., 2016) and in chemically induced colitis (Yui et al., 2018) . In the latter study, the population of cells with fetal signature were Sca1 + , as in the current study. Taken together, these suggest that injury-induced regeneration occurs from conversion of existing cell types to adopt fetal-like pathways to rapidly reestablish the steady state, possibly by re-deriving the adult stem/ progenitor cells similarly to the manner in which the tissue was originally formed. The connections drawn in these studies between developmental programs and injury-repair, including those drawn by Nusse and Savage et al. (Nusse et al., 2018) , have broad potential applications in regenerative medicine. Damage to intestinal epithelium occurs in many disease states including inflammatory bowel disease, ischemic injury, infection, and the influence of drugs. Further distillation of the precise mechanisms by which crypts can hijack fetal pathways upregulated during the injury response may enable us to specifically target these pathways to generate replacement tissues, enhance mucosal healing in vivo, or even prevent epithelial damage. Understanding the toolbox used by the epithelium for regeneration during this fetal-like reversion would enable development of novel therapeutics to add to the armamentarium for diseases affecting the gut epithelium and perhaps other tissues more broadly. + ISCs. The proliferative crypt is now sustained by heterogeneous Sca-1 + cells with reactivation of some fetal pathways that harbor regenerative potential to repair the epithelium and restore Lgr5 + ISCs.
